Retina Consultants of America
Acquisition in 2024
Retina Consultants of America is a network of retinal practices dedicated to providing comprehensive retinal care. The organization employs a physician-centered practice management model that empowers retinal specialists to deliver high-quality surgical and clinical services. By focusing on innovative treatments and supporting clinical decision-making, Retina Consultants enhances patient experiences and outcomes. The company aims to save sight and improve the lives of patients through its commitment to advancing retinal health and providing complete healthcare services.
Sempre Health
Venture Round in 2023
Sempre Health, Inc. is a healthcare technology company that operates a behavior-based healthcare pricing platform aimed at making prescription medications more affordable for patients. Founded in 2015 and based in San Francisco, the company collaborates with health plans and pharmaceutical manufacturers to dynamically adjust patients' co-payments based on their adherence to prescribed medications. By analyzing prescription records and individual patient behaviors, Sempre Health predicts the optimal price for medications at the point of sale. Patients receive personalized SMS notifications detailing potential discounts and guidance on improving their health, thereby encouraging timely prescription refills. This innovative approach not only enhances patient access to necessary medications but also contributes to better clinical outcomes while reducing overall healthcare costs. Additionally, Sempre Health is building a unique dataset on patient price sensitivities and cost behaviors to further refine its services.
SteadyMD
Venture Round in 2023
SteadyMD, Inc. is a provider of online primary care services based in St. Louis, Missouri, with an additional office in Westlake Village, California. Founded in 2016, the company connects patients with board-certified clinicians through a digital platform that facilitates telehealth services for various medical conditions, dietary preferences, and lifestyle choices. Patients can communicate with their doctors via text, call, or video chat, allowing for personalized and comprehensive care. SteadyMD also serves as a telehealth infrastructure provider, enabling healthcare leaders to scale their telehealth offerings across all 50 states by providing a licensed clinician workforce and support in clinical operations, legal, and regulatory matters. The company's innovative approach aims to improve access to high-quality care by addressing the complexities of chronic illnesses and ensuring that patients receive adequate time and attention from their healthcare providers.
OneOncology
Secondary Market in 2023
OneOncology, Inc. is a partnership of independent oncologists and industry experts focused on transforming community-based cancer care in the United States. Founded in 2007 and headquartered in Orlando, Florida, the company operates a network that supports independent oncology practices by providing essential resources and technologies. OneOncology offers AssistPoint, an enterprise workflow platform designed to streamline the administrative aspects of patient care. Additionally, it serves as an electronic distribution channel for pharmaceuticals, facilitating connections among manufacturers, physicians, distributors, and payers. Through strategic partnerships, OneOncology empowers oncologists to enhance their practices, share knowledge, and innovate in cancer care delivery, ensuring comprehensive support for patients and their families in their local communities.
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
PharmaLex
Acquisition in 2022
PharmaLex is a specialized service provider for the pharmaceutical, biotechnology, and medical device industries. The company assists clients throughout the entire product lifecycle, from early strategic planning and non-clinical requirements to clinical development, regulatory submissions, and post-launch maintenance activities. By leveraging technology-enabled solutions, PharmaLex helps companies navigate the complex regulatory landscape associated with drug and medical device approval, ensuring compliance and facilitating a quicker time to market. With a workforce of over 3,000 employees and 67 offices across 32 countries, PharmaLex serves a diverse client base, including developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies, vaccines, and biosimilars. The firm is committed to delivering customized solutions that exceed standard practices and meet the unique needs of its clients worldwide.
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
TrakCel
Corporate Round in 2021
TrakCel Ltd. is a technology company based in Cardiff, United Kingdom, specializing in integrated solutions for the cell therapy supply chain, specifically for autologous and allogeneic therapies. Founded in 2012, TrakCel offers a comprehensive Cell Orchestration Platform, a cloud-based software solution that streamlines the development of cell and gene therapies. This platform enables users to collate, track, and document essential program information, enhancing efficiency and compliance throughout various stages of therapy development. TrakCel's technology supports medical centers, logistics providers, manufacturers, and therapy sponsors by facilitating regulatory audits and addressing the data management, reporting, and analysis needs of clinical trials. By providing a scalable and validated platform, TrakCel aims to modernize and optimize the processes involved in cell and gene therapy, thereby reducing the time, cost, and risks associated with traditional paper-based systems.
H. D. Smith
Acquisition in 2017
H. D. Smith, LLC is a prominent distributor of healthcare products and business solutions in the United States, serving manufacturers and healthcare providers. Established in 1954 and headquartered in Springfield, Illinois, the company operates distribution centers in several states, including California, Florida, Kentucky, New England, New York, and Texas. H. D. Smith specializes in a wide range of products, including prescription, brand, generic, and specialty pharmaceuticals, as well as consumer goods, home healthcare supplies, durable medical equipment, and pharmacy supplies. Their customer base includes retail pharmacies, alternate care facilities, and various institutions. With a focus on excellence in healthcare distribution, H. D. Smith emphasizes a customer-centric approach, aiming to be flexible, transparent, and reliable in its operations. As of 2018, H. D. Smith operates as a subsidiary of AmerisourceBergen Corporation.
St. Francis Group
Acquisition in 2016
St. Francis Group is the largest animal health buying group in the United Kingdom, specializing in providing information and support services for veterinary products and animal health. The company offers its members a range of services designed to streamline operations, enhance purchasing advantages, and minimize administrative burdens. By leveraging technology and tailored information, St. Francis Group enables its members to concentrate on delivering high-quality clinical care, thereby improving overall efficiency in the veterinary sector.
PharMEDium Healthcare
Acquisition in 2015
PharMEDium Healthcare is a provider of customized pharmacy sterile compounding services, specializing in hospital intravenous and epidural therapies. Founded in 2003 and based in Lake Forest, Illinois, the company offers a range of compounding services, including sterile admixture, pain management, nerve block, and anesthesia services. PharMEDium Healthcare has a diverse portfolio that includes critical medications such as Calcium Chloride, Esmolol, Fentanyl, and Methadone. In October 2015, the company was acquired by AmerisourceBergen Corporation, enhancing its capabilities in the healthcare sector.
MWI Veterinary Supply
Acquisition in 2015
MWI Veterinary Supply, founded in 1976 by Millard Wallace Ickes, DVM, in Nampa, Idaho, specializes in providing a wide range of animal health products to veterinarians. Initially established to meet the needs of professionals in the Northwest, MWI has expanded its offerings to include pharmaceuticals, vaccines, dental and diagnostic supplies, veterinary pet food, grooming products, surgical equipment, X-ray machines, and nutritional items. The company's commitment to quality service and competitive pricing has fueled its growth, enabling it to serve customers across the United States effectively. MWI focuses on developing solutions that support the success of veterinary practices, ensuring both their own growth and that of their clients.
Profarma has been engaged for 52 years in the distribution of pharmaceuticals, personal care products and cosmetics. The company provides medicines, personal care, health and beauty care, oncological, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of Brazil.
World Courier
Acquisition in 2012
World Courier is a logistics service provider specializing in the transportation and storage of time- and temperature-sensitive products for the pharmaceutical industry. The company focuses on creating tailored logistics solutions that align with the strategic business objectives of its clients, aiming to enhance global health outcomes. World Courier's experienced personnel and global presence enable it to manage the complex handling and delivery of critical healthcare products effectively. By mitigating risks and ensuring optimal conditions during transport, World Courier helps pharmaceutical companies safely and cost-effectively deliver medicines, thereby maximizing the return on research and development investments and advancing medical innovation.
IntrinsiQ
Acquisition in 2011
IntrinsiQ is a provider of oncology-focused software solutions that enhance the quality and management of cancer care. Its flagship product, IntelliDose, serves as a critical resource for oncology professionals, streamlining chemotherapy treatment workflows and minimizing manual errors. This software enables healthcare providers to efficiently manage infusion and inventory processes while tracking complex chemotherapy treatments. The data collected by IntelliDose offers valuable insights into oncological practices, illuminating how oncologists treat patients and the therapies they prefer, which in turn highlights opportunities for improving patient outcomes and care. By delivering reliable information and operational support, IntrinsiQ empowers oncologists, hospitals, and pharmaceutical companies to optimize their services, enhance clinical trials, and advance drug development.
Bellco Health
Acquisition in 2007
Bellco Health is a privately held company that specializes in the distribution of both branded and generic pharmaceuticals. The company focuses on marketing and selling generic pharmaceuticals directly to individual retail pharmacies. Additionally, Bellco Health supplies pharmaceutical products and services to dialysis clinics, ensuring that these essential healthcare facilities have access to necessary medications and support.
Xcenda
Acquisition in 2007
Xcenda is a healthcare consulting firm based in Conshohocken, Pennsylvania, specializing in strategic insights and support for market access. The company provides a range of services, including health economics and outcomes research, reimbursement assistance, health policy analysis, and market research. Xcenda serves both established global companies and emerging firms in the pre-commercialization phase, helping clients navigate the complexities of the healthcare landscape and improve their market positioning. Through its expertise, Xcenda aims to deliver quality consulting services that enhance clients' understanding of market dynamics and facilitate successful product access and reimbursement strategies.
Access M.D.
Acquisition in 2006
AMD is a Canadian company providing services, including reimbursement support programs, third-party logistics and nursing support services, to manufacturers of specialty pharmaceuticals, such as injectable and biological therapies.
IgG America
Acquisition in 2006
IgG America is the specialty infusion pharmacy dedicated exclusively to providing immunoglobulin therapy. As an accredited specialty pharmacy, we have national reach and a legacy of care that spans thousands of patients.
PMSI provides Medicare set-aside cost containment services to insurance payers, primarily within the workers' compensation industry. It offers PharmaComplete solution, which addresses the retail pharmacy lifecycle by providing prescription dispensing; and DMEComplete solution that integrates network penetration strategies with clinical utilization controls to control costs, simplify claims management, and support optimal health outcomes for injured workers.
Brecon Pharmaceuticals
Acquisition in 2006
Brecon Pharmaceuticals is a privately held provider of contract packaging and clinical trial materials services for pharmaceutical manufacturers. Brecon Pharmaceuticals is one of the contract packaging and CTM companies in the United Kingdom, providing packaging services for pharmaceuticals intended for sale by pharmaceutical manufacturers throughout Europe and Asia.
Network for Medical Communications & Research
Acquisition in 2006
Network for Medical Communications & Research a privately held provider of physician accredited continuing medical education and analytical research for the oncology market.
Trent Drug
Acquisition in 2005
Trent Drug is a privately held company and one of the national pharmaceutical distributors in Canadain, categorized under Drugs, Proprietaries, and Sundries.
Anderson Packaging
Acquisition in 2003
Anderson Packaging is a privately held contract pharmaceutical packaging company providing physician samples and retail contract packaging services to pharmaceutical manufacturers.
US Bioservices
Acquisition in 2003
US Bioservices is an independent specialty pharmacy based in Frisco, Texas, and has been providing patient support solutions for over 20 years. Established in 1994 by Ethan Leder and Mark Clein, the company offers comprehensive services to physicians and pharmaceutical manufacturers, emphasizing the integration between healthcare providers and pharmacies. One of its key offerings is the MyPathpoint Portal, which enhances transparency in pharmacy operations and clinical records. In January 2003, US Bioservices was acquired by AmerisourceBergen Corporation, further solidifying its role in the healthcare landscape.
Bridge Medical
Acquisition in 2003
Bridge Medical is the leading provider of barcode-enabled point-of-care (BPOC) software designed to reduce medication errors and decrease costs in healthcare facilities.
AutoMed Technologies
Acquisition in 2002
AutoMed Technologies is a provider of automated pharmacy dispensing equipment. AutoMed is uniquely positioned in the pharmacy automation marketplace. Combining software, equipment and workflow design, AutoMed has the only truly integrated pharmacy automation solution.
Pharmacy Healthcare Solutions
Acquisition in 2000
Pharmacy Healthcare Solutions is a pharmacy consulting firm that focuses on enhancing the operations of acute-care hospitals and healthcare systems. The company provides a range of strategic, operational, and clinical consulting services aimed at improving patient care, controlling costs, and driving market growth. Key offerings include medication process and policy development, medication tracking, and coordinated patient care services. Additionally, Pharmacy Healthcare Solutions supports employee and community pharmacy services, as well as supply chain management and pharmacy inventory management solutions. The firm also specializes in ambulatory pharmacy solutions, specialty pharmacy project management, chronic disease management, medication compliance, and post-discharge care coordination, all designed to help healthcare providers reduce prescription costs and enhance the overall continuum of care.
CD Smith Healthcare
Acquisition in 1999
CD Smith Healthcare is a full-service regional pharmaceutical distributor in the U.S. and has one of the strongest market shares among all distributors in its core Midwestern U.S. territory.
Lash Group
Acquisition in 1998
Lash Group is a healthcare consulting firm. Lash Group applies highly trained personnel and a customer service philosophy of putting the patient first.